Global Dexrazoxane Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dexrazoxane Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
An antimitotic agent with immunosuppressive properties. Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection against anthracycline toxicity. It appears to inhibit formation of a toxic iron-anthracycline complex. [PubChem] The Food and Drug Administration has designated dexrazoxane as an orphan drug for use in the prevention or reduction in the incidence and severity of anthracycline-induced cardiomyopathy
Dexrazoxane report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dexrazoxane market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dexrazoxane industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Dexrazoxane key manufacturers include Bedford Laboratories, Topotarget, Pharmacia and Upjohn, Gland Pharma, Mylan, West-Ward Pharms, Clinigen, Boehringer Ingelheim and Clinigen Healthcare, etc. Bedford Laboratories, Topotarget, Pharmacia and Upjohn are top 3 players and held % sales share in total in 2022.
Dexrazoxane can be divided into 250mg and 500mg, etc. 250mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Dexrazoxane is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Dexrazoxane industry development. In 2022, global % sales of Dexrazoxane went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dexrazoxane market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bedford Laboratories
Topotarget
Pharmacia and Upjohn
Gland Pharma
Mylan
West-Ward Pharms
Clinigen
Boehringer Ingelheim
Clinigen Healthcare
Aosaikang Pharmaceutical
Segment by Type
250mg
500mg
Hospital
Drug Store
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dexrazoxane market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dexrazoxane, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dexrazoxane industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Dexrazoxane in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dexrazoxane introduction, etc. Dexrazoxane Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dexrazoxane market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Dexrazoxane report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dexrazoxane market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dexrazoxane industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Dexrazoxane key manufacturers include Bedford Laboratories, Topotarget, Pharmacia and Upjohn, Gland Pharma, Mylan, West-Ward Pharms, Clinigen, Boehringer Ingelheim and Clinigen Healthcare, etc. Bedford Laboratories, Topotarget, Pharmacia and Upjohn are top 3 players and held % sales share in total in 2022.
Dexrazoxane can be divided into 250mg and 500mg, etc. 250mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Dexrazoxane is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Dexrazoxane industry development. In 2022, global % sales of Dexrazoxane went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dexrazoxane market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bedford Laboratories
Topotarget
Pharmacia and Upjohn
Gland Pharma
Mylan
West-Ward Pharms
Clinigen
Boehringer Ingelheim
Clinigen Healthcare
Aosaikang Pharmaceutical
Segment by Type
250mg
500mg
Segment by Application
Hospital
Drug Store
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dexrazoxane market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dexrazoxane, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dexrazoxane industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Dexrazoxane in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dexrazoxane introduction, etc. Dexrazoxane Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dexrazoxane market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices